PFIZER ($PFE) posted quarterly earnings results for Q4 2025 on Tuesday, February 3rd. The company reported earnings of $0.66 per share, beating estimates of $0.58 by $0.08. The company also reported revenue of $17,557,000,000, beating estimates of $17,119,174,992 by $437,825,008.
You can see Quiver Quantitative's $PFE stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
PFIZER Hedge Fund Activity
We have seen 1,267 institutional investors add shares of PFIZER stock to their portfolio, and 1,434 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 24,513,278 shares (+55.9%) to their portfolio in Q3 2025, for an estimated $624,598,323
- WELLINGTON MANAGEMENT GROUP LLP removed 16,541,586 shares (-21.5%) from their portfolio in Q3 2025, for an estimated $421,479,611
- MILLENNIUM MANAGEMENT LLC removed 12,237,392 shares (-87.4%) from their portfolio in Q3 2025, for an estimated $311,808,748
- BNP PARIBAS FINANCIAL MARKETS removed 11,413,258 shares (-54.2%) from their portfolio in Q3 2025, for an estimated $290,809,813
- ROYAL BANK OF CANADA added 9,722,744 shares (+33.0%) to their portfolio in Q3 2025, for an estimated $247,735,517
- THORNBURG INVESTMENT MANAGEMENT INC removed 9,009,301 shares (-86.1%) from their portfolio in Q3 2025, for an estimated $229,556,989
- STARBOARD VALUE LP removed 8,542,149 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $217,653,956
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
PFIZER Government Contracts
We have seen $1,732,949 of award payments to $PFE over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- STERILE WATER FOR INJECTION 20ML: $1,167,976
- PFIZER VACCINES STORAGE AND ROTATION CONTRACT: $410,203
- 4567359319!NALOXONE 4 MG/10 ML VIAL 10ML: $59,220
- 4569494415!PROCARDIA XL 30 MG TABLET 100S: $24,723
- 4568572944!NALOXONE 4 MG/10 ML VIAL 10ML: $11,280
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
PFIZER Congressional Stock Trading
Members of Congress have traded $PFE stock 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $PFE stock by members of Congress over the last 6 months:
- REPRESENTATIVE J. FRENCH HILL sold up to $250,000 on 12/31.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 1 purchase worth up to $15,000 on 11/18 and 2 sales worth up to $30,000 on 12/19, 08/05.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
PFIZER Analyst Ratings
Wall Street analysts have issued reports on $PFE in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Guggenheim issued a "Buy" rating on 11/24/2025
To track analyst ratings and price targets for PFIZER, check out Quiver Quantitative's $PFE forecast page.
PFIZER Price Targets
Multiple analysts have issued price targets for $PFE recently. We have seen 7 analysts offer price targets for $PFE in the last 6 months, with a median target of $27.0.
Here are some recent targets:
- Carter Gould from Cantor Fitzgerald set a target price of $27.0 on 01/27/2026
- Michael Yee from UBS set a target price of $25.0 on 01/07/2026
- Terence Flynn from Morgan Stanley set a target price of $27.0 on 12/17/2025
- Jason Gerberry from B of A Securities set a target price of $28.0 on 12/15/2025
- Geoff Meacham from Citigroup set a target price of $26.0 on 12/02/2025
- Vamil Divan from Guggenheim set a target price of $35.0 on 11/24/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
